KARYOPHARM THERAPEUTICS INC (KPTI)

US48576U1060 - Common Stock

1.38  +0.28 (+25.45%)

Premarket: 1.41 +0.03 (+2.17%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
146.03M157.10M209.80M108.10M40.90M
Cost Of Goods
4.94M5.20M3.40M2.70M2.40M
Gross Profit
141.09M151.90M206.40M105.40M38.50M
Operating Expenses
270.63M294.10M304.70M277.20M227.80M
Research and Development
138.75M148.70M160.80M150.80M122.30M
Selling, General, and Administrative Expenses
131.88M145.40M143.80M126.40M105.40M
Operating Income
-129.54M-142.20M-98.30M-171.90M-189.30M
Interest Income/Expense
-12.88M-22.60M-25.50M-24.30M-10.20M
Other Income/Expense
-356.00K-100.00K-100.00K200.00K-100.00K
Income Before Taxes
-142.78M-164.90M-123.80M-196.00M-199.60M
Income Tax
323.00K400.00K300.00K300.00K0.00
Net Income
-143.10M-165.30M-124.10M-196.30M-199.60M
EBITDA
-129.01M-141.58M-97.51M-170.93M-188.33M
 
Per Share Data
EPS Diluted Total Ops
-1.25-2.02-1.65-2.72-3.22
Non GAAP EPS
-1.25-2.03-1.71-2.73-3.23
 
Statistics
Gross Profit Margin
96.62%96.69%98.38%97.50%94.13%
Profit Margin
-97.99%-105.22%-59.15%-181.59%-488.02%
Operating Profit Margin
-88.71%-90.52%-46.85%-159.02%-462.84%

All data in USD

Charts